Search Site

TAQA net income $1.93bn in 2024

The company's revenues increased 6.7 percent year-on-year.

ADNOC L&S 2024 net profit $756m

The company's revenue increased by 29 percent to $3.54 billion.

ADNOC Distribution 2024 net profit down 7%

Minus UAE corporate tax, it would have grown by 2.4% to $725m

Maaden raises $1.25bn in sukuk offering

The Sukuk were offered in a five-year and a 10-year tranche.

DAE net profit up 36.2%

Revenues grew by 9 percent to $1.42bn from $1.31bn in 2023.

Global vaccine program COVAX seeks $5.2b in funding

COVAX's initial goal was to deliver 2 billion doses by the end of 2021. AFP
  • COVAX's initial goal was to deliver 2 billion doses by the end of 2021, but its lack of cash when vaccine deals were made delayed its delivery
  • Nearly 1 billion doses of the United Nations-backed COVAX program have been delivered since the shipments began nearly a year ago

The global initiative to share Coronavirus vaccines equally between rich and poor countries is seeking $5.2 billion in funding in order to be able to continue to purchase vaccines in the coming months.

Approximately 1 billion doses of the United Nations-backed COVAX program have been delivered since the shipments began nearly a year ago, according to an Associated Press report.

COVAX’s initial goal was to deliver 2 billion doses by the end of 2021, but its lack of cash when vaccine deals were made delayed its delivery, and the majority of vaccine doses have gone to wealthy nations that are locked into contracts.

At present, less than 10% of people in low-income countries have received at least one dose, while more than 60% of the world’s total population has been immunized, some with three or four doses.